Drugs Information: Ibritumomab tiuxetan
Basic Information
|
||
| ID | DDInter898 | |
| Drug Type | biotech | |
| Molecular Formula | C6382H9830N1672O1979S54 | |
| Molecular Weight | - | |
| Description | Ibritumomab tiuxetan is a monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. | |
| ATC Classification | V10XX02 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Ibritumomab tiuxetan
| Severity level | ID | Name | Mechanism | Detail |
|---|